Search Results - "Turon, Janina"
-
1
Distal hereditary motor neuropathies: Mutation spectrum and genotype–phenotype correlation
Published in European journal of neurology (01-04-2021)“…Background and purpose Distal hereditary motor neuropathies (dHMNs) are a heterogeneous group of disorders characterized by degeneration of the motor component…”
Get full text
Journal Article -
2
Cortical microstructure in the amyotrophic lateral sclerosis–frontotemporal dementia continuum
Published in Neurology (03-11-2020)“…OBJECTIVETo characterize the cortical macrostructure and microstructure of behavioral and cognitive changes along the amyotrophic lateral sclerosis…”
Get full text
Journal Article -
3
Leptospirosis‐induced acute acquired inflammatory neuropathy
Published in Journal of the peripheral nervous system (01-03-2023)“…Leptospirosis is a zoonotic infection that can present with neurological manifestations. Although uncommon, it may affect the peripheral nervous system in the…”
Get full text
Journal Article -
4
Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease
Published in European journal of neurology (01-04-2023)“…Background and purpose The aim of this study was to describe the frequency and distribution of SOD1 mutations in Spain, and to explore factors contributing to…”
Get full text
Journal Article -
5
A new de novo SYT2 mutation presenting as distal weakness. Neuropathy or neuromuscular junction dysfunction?
Published in Journal of the peripheral nervous system (01-03-2021)“…We report the case of a patient with a clinical phenotype characterized by distal lower limb weakness and pes cavus. The electrophysiological study showed…”
Get full text
Journal Article -
6
Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis
Published in Neurobiology of disease (01-04-2019)“…ErbB4 is a transmembrane receptor tyrosine kinase that binds to neuregulins to activate signaling. Proteolytic cleavage of ErbB4 results in release of soluble…”
Get full text
Journal Article Web Resource -
7
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
Published in Frontiers in neurology (18-01-2022)“…Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) lie at opposing ends of a clinical, genetic, and neuropathological continuum…”
Get full text
Journal Article -
8
CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum
Published in Neurology (23-10-2018)“…OBJECTIVETo investigate the clinical utility of 3 CSF biomarkers along the clinical spectrum of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia…”
Get full text
Journal Article -
9
Clinical characteristics and outcomes of thymoma‐associated myasthenia gravis
Published in European journal of neurology (01-06-2021)“…Background and purpose Prognosis of myasthenia gravis (MG) in patients with thymoma is not well established. Moreover, it is not clear whether thymoma…”
Get full text
Journal Article -
10
Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy
Published in Brain (London, England : 1878) (01-04-2019)“…Cortical mean diffusivity has been proposed as a useful biomarker for the study of cortical microstructure in neurodegenerative diseases. Illán-Gala et al…”
Get full text
Journal Article -
11
A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID‐19 years
Published in European journal of neurology (01-12-2024)“…Background and purpose The purpose was to perform a nationwide epidemiological study of Guillain–Barré syndrome (GBS) in Spain, analysing background incidences…”
Get full text
Journal Article -
12
Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants
Published in Brain pathology (Zurich, Switzerland) (01-05-2021)“…Cognitive impairment and behavioral changes in amyotrophic lateral sclerosis (ALS) are now recognized as part of the disease. Whether it is solely related to…”
Get full text
Journal Article -
13
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis
Published in Neurology : neuroimmunology & neuroinflammation (01-09-2020)“…OBJECTIVETo identify transcriptomic changes, neuropathologic correlates, and cellular subpopulations in the motor cortex of sporadic amyotrophic lateral…”
Get full text
Journal Article -
14
Professor Isabel Illa (1952 - 2022)
Published in Neuromuscular disorders : NMD (01-05-2022)Get full text
Journal Article -
15
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
Published in Alzheimer's & dementia : translational research & clinical interventions (2019)“…The SPIN (Sant Pau Initiative on Neurodegeneration) cohort is a multimodal biomarker platform designed for neurodegenerative disease research following an…”
Get full text
Journal Article -
16
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Published in Annals of clinical and translational neurology (01-02-2022)“…Objective To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side…”
Get full text
Journal Article -
17
Mutation update for the ACTN2 gene
Published in Human mutation (01-12-2022)“…ACTN2 encodes alpha‐actinin‐2, a protein expressed in human cardiac and skeletal muscle. The protein, located in the sarcomere Z‐disk, functions as a link…”
Get full text
Journal Article -
18
A nationwide Guillain–Barré syndrome epidemiological study in Spain during the COVID‐19years
Published in European journal of neurology (01-12-2024)“…Background and purposeThe purpose was to perform a nationwide epidemiological study of Guillain–Barré syndrome (GBS) in Spain, analysing background incidences…”
Get full text
Journal Article -
19
CORTICAL MICROSTRUCTURAL CHANGES IN FRONTOTEMPORAL LOBAR DEGENERATION: A NEW IMAGING BIOMARKER
Published in Alzheimer's & dementia (01-07-2017)Get full text
Journal Article -
20
Rituximab in myasthenia gravis: efficacy, associated infections and risk of induced hypogammaglobulinemia
Published in Neuromuscular disorders : NMD (01-08-2022)“…•Rituximab is effective in patients with myasthenia gravis.•Patients with Anti-MusK antibodies respond better.•Severe infections may appear after rituximab…”
Get full text
Journal Article